PRESS: Fierce Biotech - Forge Biologics

Six months after departing Abeona, Tim Miller, Ph.D., is on his next chapter: Forge Biologics, a gene therapy biotech that’s []Read More from PRESS: Fierce Biotech

Forge Biologics

Forge Biologics Manufacturing Gene Therapies for Life

Forge Biologics Announces Closing of $120 Million Series B Financing

Forge Biologics Manufacturing Gene Therapies for Life

Fierce Biotech's 2022 Fierce 15

Forge Announces Regulatory Updates from FDA and EMA, Accelerating Manufacturing and Clinical Trial Momentum - Forge Biologics

Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1

Recon: AstraZeneca priorities US market for RSV drug; Japan to ease rules on testing new drugs overseas

Forge Biologics Manufacturing Gene Therapies for Life

Forge Biologics Manufacturing Gene Therapies for Life

Forge Biologics expanding, leading the way in gene therapy